EU-US reach landmark deal on mutual recognition of manufacturing inspection
March 3, 2017Medical Communications EMA, EU, FDA, US
The European Union and the US has announced that an agreement has been made to mutually recognise inspection of drug …
Price cuts bring 14 Cancer Drugs Fund treatments into routine NHS use
March 3, 2017Medical Communications, Sales and Marketing CDF, NICE
NICE has revealed that it has reached the halfway point in its review of the old Cancer Drugs Fund (CDF) …
CMA accuses Concordia and Actavis of illegal agreement to maintain high prices
March 3, 2017Medical Communications, Sales and Marketing Actavis UK, CMA, Concordia, competition and markets authority
The Competition and Markets Authority (CMA) has alleged that Concordia and Actavis UK entered into a clandestine agreement to maintain …
Ipsen appoints new Executive Vice President
March 2, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ipsen
Ipsen has announced the appointment of Benoit Hennion as Executive Vice President and President of Primary Care. Hennion has worked …
Juno Therapeutics abandons problem leukaemia drug
March 2, 2017Juno Therapeutics has finally called time on the development of its CAR-T therapy, JCAR015, after one of the most turbulent …
Are we prepared for the ‘real world’?
March 2, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing opinion, real world data, recruitment
Dr Dilruwan Chaminda Herath, Medical Director for Chiesi Group, discusses whether the lack of impetus to push for recruitment of …
NICE approves first biliary cholangitis drug in 20 years
March 2, 2017Sales and Marketing Intercept Pharmaceuticals, intercept, liver disease, ocaliva, primary biliary cholangitis
Intercept Pharmaceuticals has announced that Ocaliva (obeticholic acid) has been approved by the National Institute for Health and Care Excellence …
Osteoporosis drugs potentially causing long-term bone weakness
March 2, 2017Research and Development osteoporosis
Medication that is used to treat those suffering from weakened bones may actually be causing further damage, new research from …
Roche’s neoadjuvant breast cancer combo therapy shows strong Phase 3 results
March 2, 2017Research and Development Herceptin, Perjeta, Roche
Roche’s combination treatment of Perjeta (pertuzumab), Herceptin (trasdtuzumab) and chemotherapy met its primary endpoint in a recent Phase 3 study. …
South Korea fines Novartis over kickbacks scandal
March 2, 2017Medical Communications, Sales and Marketing Kickback, Novartis, south korea
South Korea’s Ministry of Food and Drug Safety has fined Novartis 200 million won ($174,936) over the payment of kickbacks …
New COO for Celgene
March 1, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene
Celgene released in a statement that its Chief Operating Officer and President, Jacqualyn “Jackie” Fouse, will retire from her position. …
Pfizer plant receives FDA warning letter for contamination of medicine
March 1, 2017Manufacturing and Production Copaxone, Mylan, Pfizer, Teva, generics
The FDA has issued a warning letter to Pfizer after inspectors discovered that the plant did not protect properly against …
Graham Dunkley chooses Medica’s Pharma Cartons
March 1, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Medica Packaging
Medica Packaging is pleased to announce that Graham Dunkley, most recently of Multi Packaging Solutions (MPS) has joined Medica as …
Promising anti-cocaine treatment aims for human trials within a year
March 1, 2017Research and Development University of Cincinnati, cocaine, immunotherapy
Researchers at the University of Cincinnati (UC) have developed a monocloncal antibody designed to treat cocaine addiction; its successful showing …
Asthma drugs may have alternative function as pneumonia treatment
March 1, 2017Research and Development asthma, influenza, pneumonia
Researchers from the University of Virginia School of Medicine have discovered that two drugs commonly used to treat asthma, Accolate …
Kite Pharma climbs on strong data showing in lymphoma trial
March 1, 2017Research and Development kite pharma, non-Hodgkin lymphoma
Kite Pharma released the news on Rare Diseases Day promising top-line data from a Phase 1/2 trial of its treatment …
Novo Nordisk’s Head of North America resigns
March 1, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, appointment
Novo Nordisk has announced the surprising news that its Executive Vice President, Head of North American Operations Jakob Riis has …
NICE knocks back MSD’s Keytruda for lung cancer indication
February 28, 2017Research and Development, Sales and Marketing MSD, NICE, NSCLC, keytruda
MSD’s immunotherapy drug Keytruda (pembrolizumab) has been knocked back by the National Institute of Health and Care Excellence (NICE) for …
WHO releases list of bacteria that pose greatest threat to humankind
February 28, 2017Research and Development WHO, antibiotic resistance
The World Health Organisation (WHO) has published a list of the 12 bacteria that are thought to present the largest …
FDA green lights AstraZeneca type-2 diabetes drug
February 28, 2017Manufacturing and Production, Sales and Marketing AstraZeneca, FDA
AstraZeneca has announced that its type-2 diabetes treatment Qtern (10mg dapagliflozin and 5mg saxagliptin) has received the approval of the …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
